Skip to main content
Mark Kohler, MD, Pediatric Hematology & Oncology, Aurora, CO, Children's Hospital Colorado

MarkEricKohlerMDPhD

Pediatric Hematology & Oncology Aurora, CO

Pediatric Hematologic Oncology

Instructor of Pediatrics, Children's Hospital Colorado University of Colorado

Dr. Kohler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kohler's full profile

Already have an account?

  • Office

    Children's Hospital Colorado
    13123 E 16th Ave
    Aurora, CO 80045
    Phone+1 720-777-6892
    Fax+1 720-777-7346
  • Is this information wrong?

Education & Training

  • National Capital Consortium
    National Capital ConsortiumFellowship, Pediatric Hematology/Oncology, 2014 - 2018
  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2014 - 2018
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Pediatrics, 2011 - 2014
  • Medical College of Wisconsin
    Medical College of WisconsinClass of 2011
  • Medical College of Wisconsin
    Medical College of WisconsinPhD, Immunology , 2004 - 2009
  • Rockhurst University
    Rockhurst UniversityBS, Biology, Chemistry , Summa Cum Laude, 1997 - 2001

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2018 - 2025
  • MD State Medical License
    MD State Medical License 2014 - 2018
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Crystal Mackall Award for Pediatric Oncology Reserch Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, 2018
  • Abstract Achievement Award American Society of Hematology, 2018

Publications & Presentations

PubMed

Books/Book Chapters

Abstracts/Posters

  • A Direct Comparison of the In Vivo Efficacy and In Vitro Signaling of Chimeric Antigen Receptors and Endogenous T Cell Receptors.
    Kohler, ME, Yang, Y, Sepulveda, G, Fry, TJ., American Society of Hematology 59th Annual Meeting, Atlanta, GA, 12/2017
  • Effect of Chronic Endogenous Antigen Stimulation on CAR T Cell Persistence and Memory Formation
    Yang, Y, Kohler, ME, Fry, TJ, American Society of Hematology 59th Annual Meeting, Atlanta, GA, 12/2017
  • Modeling Retreatment of Acute Lymphoblastic Leukemia with Anti-CD19 Chimeric Antigen Receptor T Cell Therapy
    Yang, Y, Kohler, ME, Fry, TJ, American Society of Hematology 58th Annual Meeting, San Diego, CA, 12/2016
  • Join now to see all

Press Mentions

  • Health Crisis Has Created a Potential $250 Billion Telehealth Opportunity
    Health Crisis Has Created a Potential $250 Billion Telehealth OpportunitySeptember 16th, 2020
  • CloudMD Is My TeleHealth Stock
    CloudMD Is My TeleHealth StockApril 30th, 2020
  • Hyundai Hope on Wheels Presents Children's Hospital Colorado with $200,000 Hyundai Young Investigator Grant to Support Pediatric Cancer Research
    Hyundai Hope on Wheels Presents Children's Hospital Colorado with $200,000 Hyundai Young Investigator Grant to Support Pediatric Cancer ResearchSeptember 6th, 2019

Grant Support

  • Paul Calabresi Clinical Scholars AwardUniversity of Colorado Cancer Center2019–2021
  • Defining the signal transduction pathways of Chimeric Antigen Receptors (CAR) as a means to increase the efficacy of CAR T cell therapy for pediatric leukemiasHyundai Hope on Wheels2019–2021
  • CD99 targeting CAR T cells as a novel therapy for H3K27M mutant DIPGCancer League of Colorado2019–2020

Hospital Affiliations